D.A. Sychev, O.D. Ostroumova, A.P. Pereverzev, A.I. Kochetkov, M.V. Klepikova, E.Yu. Ebzeeva, V.A. De
Risk factors of drug-induced diseases. Part 2. Comorbid diseases and lifestyle factors
|
№12 / 2021
|
N.I. Volkova, S.O. Panenko, A.O. Golubeva
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
|
№12 / 2021
|
A.F. Verbovoy, Yu.A. Dolgikh
Insulin resistance – a common enemy for endocrinologists and cardiologists
|
№12 / 2021
|
A.A. Olina (1), E.L. Makarova (2)
Vitamin d3 – a necessary component at the stage of preconception preparation
|
№6 / 2019
|
M.V. Gorbunova, S.L. Babak, A.G. Malyavin
Diagnostic algorithm and reasonable therapy of patients with obstructive sleep apnea and resistant arterial hypertension
|
№5 / 2019
|
T.N. Markova (1, 2)
Obesity and associated diseases. Modern possibilities of prevention and treatment in real clinical practice
|
№4 / 2019
|
L.V. Tarasova (1, 2, 3), Yu.V. Tsyganova (3), E.I. Busalaeva (3, 4), O.L. Aryamkina (1)
Analysis of the methods of treatment of non-alcoholic fatty liver disease: focus on innovations
|
№2 / 2019
|
G.L. Yurenev, E.M. Mironova, D.N. Andreev, T.V. Yureneva-Thorzhevskaya
CLINICAL AND PATHOGENETIC PARALLELS GASTROESOPHAGEAL REFLUX DISEASE AND OBESITY
|
№13 / 2017
|
V.I.Simanenkov, S.V. Tikhonov
GASTROENTEROLOGICAL ASPECTS OF BARIATRIC SURGERY
|
№s5-16 / 2016
|
A.F. Verbovoy, R.I. Sagirova, Yu. A. Dolgikh
OBESITY AND BRONCHIAL ASTHMA
|
№16 / 2016
|
A.F. Verbovoy, R.I. Sagirova, Yu. A. Dolgikh, L.A. Sharonova
SOME ASPECTS OF PATHOGENESIS OF INSULIN RESISTANCE
|
№16 / 2016
|
L.V. Egshatyan (1), A.M. Mkrtumyan (1), L.A. Zvenigorodskaya (2)
METABOLIC SYNDROME AND INTESTINAL MICROBIOTA
|
№16 / 2016
|